Pre-Eclampsia Pipeline Insights Report 2024 Featuring Gmax Biopharm, Vicore Pharma, and Comanche Biopharma
27 févr. 2024 11h26 HE
|
Research and Markets
Dublin, Feb. 27, 2024 (GLOBE NEWSWIRE) -- The "Pre-Eclampsia - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report report provides comprehensive...
Pre-Eclampsia - Pipeline Insight, 2023: Featuring Analysis of Key Projects from Kyowa Kirin, Gmax Biopharm and Vicore Pharma
24 mai 2023 04h28 HE
|
Research and Markets
Dublin, May 24, 2023 (GLOBE NEWSWIRE) -- The "Pre-Eclampsia - Pipeline Insight, 2023" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides comprehensive insights...